Your session is about to expire
← Back to Search
Arm A: Enhanced Dermatologic Management for Non-Small Cell Lung Cancer (COCOON Trial)
COCOON Trial Summary
"This trial aims to see if better dermatologic care can help lower the occurrence of skin issues in lung cancer patients receiving specific treatment."
COCOON Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCOCOON Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.COCOON Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the current number of individuals under observation in this clinical investigation?
"A total of 180 eligible patients are needed to enroll in this medical research. Patients meeting the set criteria can partake in the trial at diverse locations, including National Taiwan University Hospital in Taipei, Illinois and Gundersen Health System in W. Salem, New york."
At how many different sites is this study currently being managed?
"The current patient recruitment phase is ongoing at 7 diverse sites, including Taipei, W. Salem, and Kuching among others. Opting for the nearest location is advised to reduce travel burden upon enrollment."
What is the level of safety associated with Arm A: Enhanced Dermatologic Management for individuals?
"Based on our evaluation, the safety rating for Arm A: Enhanced Dermatologic Management is 2 as it corresponds to a Phase 2 trial with existing safety data but lacking efficacy evidence."
Share this study with friends
Copy Link
Messenger